Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis

Author:

Katsumi Tatsuya1,Hayashi Ryota1ORCID,Takei Shingo1ORCID,Ansai Osamu1ORCID,Takatsuka Sumiko2,Takenouchi Tatsuya2ORCID,Saito Kyota3,Suda Kazuaki3,Yoshihara Kosuke3,Nagai Takahiro4,Okuda Shujiro45,Fukumoto Takaya6,Ansai Shin‐ichi7ORCID,Nakamura Anna1,Katsuumi Koji1,Ariizumi Takashi8,Ogose Akira9,Kawashima Hiroyuki8,Abe Riichiro1ORCID

Affiliation:

1. Division of Dermatology Niigata University Graduate School of Medicine and Dental Sciences Niigata Japan

2. Division of Dermatology Niigata Cancer Center Hospital Niigata Japan

3. Department of Obstetrics and Gynecology Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

4. Center for Genomic Data Management Niigata University Medical and Dental Hospital Niigata Japan

5. Division of Bioinformatics Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

6. Fukumoto Dermatopathology Clinic Nara Japan

7. Pathology & Cytology Laboratories Japan Tokyo Japan

8. Division of Orthopedic Surgery Niigata University Graduate School of Medical and Dental Sciences Niigata Japan

9. Department of Orthopedic Surgery Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital Minamiuonuma Japan

Abstract

AbstractSchwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.

Publisher

Wiley

Reference26 articles.

1. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis;Tamura R;Int J Mol Sci,2021

2. Germline loss‐of‐function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas;Piotrowski A;Nat Genet,2014

3. Germline mutation of INI1/SMARCB1 in familial schwannomatosis;Hulsebos TJ;Am J Hum Genet,2007

4. S‐100 protein in soft‐tissue tumors derived from Schwann cells and melanocytes;Stefansson K;Am J Pathol,1982

5. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems;Rodriguez FJ;Acta Neuropathol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3